SCHEMBL2833258

SCHEMBL2833258

CCCCCCn1cc[n+](C)c1.COS(=O)(=O)[O-]

nearest known ligand 0.69

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.69
HSP90AA1 P07900 2/20 0.69
KMT2A Q03164 2/20 0.69
SMN1; SMN2 Q16637 2/20 0.69
APAF1 O14727 1/20 0.69
NPC1 O15118 1/20 0.69
PLA2G1B P04054 1/20 0.69
MAPT P10636 1/20 0.69
MAPK1 P28482 1/20 0.69
HTT P42858 1/20 0.69
RAB9A P51151 1/20 0.69
NPSR1 Q6W5P4 1/20 0.69
ATG4B Q9Y4P1 1/20 0.69
FDPS P14324 17/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL411936 1.00 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL2831918 1.00 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL411658 1.00 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL15170066 1.00 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL409277 1.00 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL15170278 0.99 MEN1 (0.67) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL305739 0.94 MEN1 (0.59) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL31072161 0.91 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Sulfuric Acid SCHEMBL31650675 0.91 MEN1 (0.78) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Sulfuric Acid SCHEMBL31650730 0.91 MEN1 (0.78) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY CUSTOMARRAY INC (US) 2021-12-23 US claimed
CN-107596874-A A kind of environmental-friendfilm film and preparation method for being used to administer air volatile organic matter 成都新柯力化工科技有限公司 2018-01-19 CN claimed
CN-104812465-B Membrane-based exhaust gas scrubbing method and system 江苏优拿大环保科技有限公司 2017-03-15 CN claimed
CN-105885058-A Method utilizing crop straws to prepare sodium lignosulfonate 吴迪 2016-08-24 CN claimed
US-20160130998-A1 MEMBRANE-BASED EXHAUST GAS SCRUBBING METHOD AND SYSTEM IONADA INCORPORATED 2016-05-12 US claimed
US-20160051927-A1 MEMBRANE-BASED EXHAUST GAS SCRUBBING METHOD AND SYSTEM IONADA INCORORATED 2016-02-25 US claimed
US-20150300231-A1 MEMBRANE-BASED EXHAUST GAS SCRUBBING METHOD AND SYSTEM IONADA PLC (MH) 2015-10-22 US claimed
US-9126848-B2 Synthesis of nanoparticles by means of ionic liquids Leibniz-Insitut fuer Neue Materialien gemeinnuetzige GmbH (DE) 2015-09-08 US claimed
CN-104812465-A Membrane-based exhaust gas scrubbing method and system IONADA INC 2015-07-29 CN claimed
US-20130341561-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY CUSTOMARRAY, INC. (US) 2013-12-26 US claimed
US-7718579-B2 Electrochemical deblocking using a hydrazine derivative COMBIMATRIX CORPORATION (US) 2010-05-18 US claimed
EP-1869061-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY Combimatrix Corporation (US) 2007-12-26 EP claimed
EP-1805206-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE Combimatrix Corporation (US) 2007-07-11 EP claimed
US-20070034513-A1 Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array COMBIMATRIX CORPORATION 2007-02-15 US claimed
WO-2006105037-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY COMBIMATRIX CORPORATION (US) 2006-10-05 WO claimed
WO-2006031814-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE COMBIMATRIX CORPORATION (US) 2006-03-23 WO claimed
US-20060054511-A1 Electrochemical deblocking using a hydrazine derivative CUSTOMARRAY, INC. 2006-03-16 US claimed
US-12503936-B1 Fracturing fluid recovery with ionic liquid KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-12-23 US disclosed
WO-2006063654-A1 METHOD FOR PRODUCING ONIUM ALKYL SULFATES WITH A LOW HALOGENIDE CONTENT MERCK PATENT GMBH (DE) 2006-06-22 WO disclosed
US-20060054511-A1 Electrochemical deblocking using a hydrazine derivative CUSTOMARRAY, INC. 2006-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY DNMT1, DNASE1, DNPEP MEN1 1771/4885HSP90AA1 3933/4885KMT2A 3944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.